ROTARIX, oral suspension in a soft tube. vaccine for rotavirus, live tube, 1.5 ml
Active ingredients: ROTAVIRUS HUMAIN (SOUCHE RIX4414) (VIVANT, ATTÉNUÉ)
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensiontube, 1.5 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROTARIX, suspension buvable en tube souple. Vaccin à rotavirus, vivant
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 tube souple polyéthylène de 1,5 mL
- Marketing authorisation holder
- GLAXOSMITHKLINE BIOLOGICALS
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 May 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60886387CIP73902022CIP133400939020228Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROTAVIRUS HUMAIN (SOUCHE RIX4414) (VIVANT, ATTÉNUÉ)suspension | au moins 1 000 000 DICC50 · une dose de 1,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.